Two different series of novel β-ketoamide curcumin analogs enriched in biological activities have been synthesized. The synthesized compounds were screened for their in vitro anti-diabetic and AGEs inhibitoryactivities and exhibited potent to good anti-diabetic and AGEs inhibitoryactivities. The molecular docking study was also performed with the α-amylase enzyme.